FDA NDC Directory · JSON-LD · Markdown

Entyvio

NDC 64764-300 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic namevedolizumab
Labeler / ManufacturerTakeda Pharmaceuticals America, Inc.
Marketing categoryBiologic License Application · App BLA125476
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsVEDOLIZUMAB (300 mg/5mL)
Marketing started20140520
Package count1

External sources

Source: openFDA. Public-domain (CC0).